1. Home
  2. VVOS vs NEPH Comparison

VVOS vs NEPH Comparison

Compare VVOS & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • NEPH
  • Stock Information
  • Founded
  • VVOS 2016
  • NEPH 1997
  • Country
  • VVOS United States
  • NEPH United States
  • Employees
  • VVOS N/A
  • NEPH N/A
  • Industry
  • VVOS Medical Specialities
  • NEPH Medical/Dental Instruments
  • Sector
  • VVOS Health Care
  • NEPH Health Care
  • Exchange
  • VVOS Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • VVOS 19.4M
  • NEPH 15.9M
  • IPO Year
  • VVOS 2020
  • NEPH 2004
  • Fundamental
  • Price
  • VVOS $5.03
  • NEPH $1.60
  • Analyst Decision
  • VVOS Strong Buy
  • NEPH Buy
  • Analyst Count
  • VVOS 2
  • NEPH 1
  • Target Price
  • VVOS $6.30
  • NEPH $5.00
  • AVG Volume (30 Days)
  • VVOS 343.2K
  • NEPH 9.9K
  • Earning Date
  • VVOS 11-14-2024
  • NEPH 03-06-2025
  • Dividend Yield
  • VVOS N/A
  • NEPH N/A
  • EPS Growth
  • VVOS N/A
  • NEPH N/A
  • EPS
  • VVOS N/A
  • NEPH N/A
  • Revenue
  • VVOS $14,581,000.00
  • NEPH $13,546,000.00
  • Revenue This Year
  • VVOS $12.35
  • NEPH N/A
  • Revenue Next Year
  • VVOS $26.02
  • NEPH $9.13
  • P/E Ratio
  • VVOS N/A
  • NEPH N/A
  • Revenue Growth
  • VVOS 0.54
  • NEPH 0.03
  • 52 Week Low
  • VVOS $1.91
  • NEPH $1.36
  • 52 Week High
  • VVOS $9.14
  • NEPH $3.83
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 54.52
  • NEPH 55.59
  • Support Level
  • VVOS $4.94
  • NEPH $1.48
  • Resistance Level
  • VVOS $6.28
  • NEPH $1.57
  • Average True Range (ATR)
  • VVOS 0.56
  • NEPH 0.06
  • MACD
  • VVOS 0.04
  • NEPH 0.01
  • Stochastic Oscillator
  • VVOS 44.12
  • NEPH 71.43

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

Share on Social Networks: